Search research articles
Contact Us
Filters
Showing results (61-70 of 137) with videos related to
Page
of 14
Sort By:
Blood Advances
|
December 21, 2021
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Aaron T Gerds, Bart L Scott, Peter Greenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2018
Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al
Remco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Leukemia Research
|
March 9, 2019
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
Aaron T Gerds, Tetsuzo Tauchi, Ellen Ritchie, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 15, 2023
Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical Outcomes
John Mascarenhas, Claire Harrison, Tammy A Schuler, et al.
American Journal of Hematology
|
April 5, 2017
The association of histologic grade with acute graft-versus-host disease response and outcomes
Mayur Narkhede, Lisa Rybicki, Donna Abounader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2016
Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Sanghee Hong, Lisa Rybicki, Donna Abounader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation
Sagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Blood Neoplasia
|
October 28, 2025
Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United States
Sudipto Mukherjee, Weichuan Dong, Aaron T Gerds, et al.
Leukemia & Lymphoma
|
August 31, 2017
Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Allison Winter, Lisa Rybicki, Shetal N Shah, et al.
Blood Cancer Journal
|
January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 137) with videos related to
Sort By:
Page
of 14
Blood Advances
|
December 21, 2021
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Aaron T Gerds, Bart L Scott, Peter Greenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2018
Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al
Remco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Leukemia Research
|
March 9, 2019
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
Aaron T Gerds, Tetsuzo Tauchi, Ellen Ritchie, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 15, 2023
Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical Outcomes
John Mascarenhas, Claire Harrison, Tammy A Schuler, et al.
American Journal of Hematology
|
April 5, 2017
The association of histologic grade with acute graft-versus-host disease response and outcomes
Mayur Narkhede, Lisa Rybicki, Donna Abounader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2016
Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Sanghee Hong, Lisa Rybicki, Donna Abounader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation
Sagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Blood Neoplasia
|
October 28, 2025
Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United States
Sudipto Mukherjee, Weichuan Dong, Aaron T Gerds, et al.
Leukemia & Lymphoma
|
August 31, 2017
Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Allison Winter, Lisa Rybicki, Shetal N Shah, et al.
Blood Cancer Journal
|
January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Page
of 14